Press - IVI

26 March 2026

An antidiabetic drug and a plant-derived compound: a new approach to improve treatment outcomes and reduce miscarriage risk in assisted reproduction

A pioneering study using advanced genetic and molecular data analysis techniques—including AI algorithms—has identified endometrial genetic profiles that can predict miscarriage risk even with top-quality embryos IVI’s presence at the SRI Congress was also marked by another study linking Body Mass Index (BMI) to pregnancy loss risk, which may increase by up to 18% PUERTO… View Article

14 March 2026

Obesity and diabetes medications open new pathways for the treatment of endometriosis

This disease directly compromises female fertility and increases the risk of pregnancy complications such as preeclampsia or miscarriage. Endometriosis affects 14 million women in Europe. According to the World Health Organization (WHO), approximately 1 in 10 women of reproductive age is affected. Specialists highlight the importance of early diagnosis, fertility preservation, and a multidisciplinary approach…. View Article

26 December 2025

A Groundbreaking Model Enables the Study of Human Embryo Implantation in the Lab up to Day 14

Researchers from IIS La Fe, the IVI Foundation, Stanford University, and the Babraham Institute have developed the first in vitro model that closely replicates the human endometrium This system allows researchers to simulate human embryo implantation up to day 14 of development—the legal limit for study This scientific breakthrough opens the door to better understanding… View Article

1 December 2025

Born HIV-Free: The Key Role of Assisted Reproduction for HIV-Positive Parents

Thanks to current reproductive technologies, individuals living with HIV who wish to build a family can do so safely and without significant risk of transmitting the virus to their baby The first step toward a safe pregnancy is proper management of antiretroviral treatment, which allows the viral load to remain at undetectable levels One of… View Article

29 October 2025

New Advances in Reproductive Bioengineering: Ovarian and Endometrial Organoids Open New Paths for Egg Preservation and Uterine Tissue Regeneration

These organoids are three-dimensional structures grown in the lab from cells that mimic the shape and function of the target organ or tissue One of the most promising applications of ovarian organoids is the preservation and restoration of fertility in women whose ovaries have been damaged due to cancer treatments In the case of human… View Article

2 July 2025

Umbilical Cord–Derived Platelet-Rich Plasma: A New Approach to Reducing Infertility and Implantation Failure in Women with Endometrial Pathologies

This pioneering study documents, for the first time, the use of allogeneic (donor-derived) platelet-rich plasma (PRP) obtained from umbilical cord blood as a treatment to regenerate atrophic or thin endometrium, as well as in cases of Asherman’s syndrome Allogeneic PRP contains a significantly higher concentration of growth factors and anti-inflammatory properties than autologous PRP, thanks… View Article

1 July 2025

Breakthrough in Male Fertility: Hyperspectral Imaging Enables Selection of Sperm with Higher Reproductive Potential

For the first time, using only light and a hyperspectral camera, this non-invasive technology captures the molecular fingerprint of individual sperm cells and generates a biochemical profile, allowing prediction of their ability to produce a viable embryo The technique does not damage or compromise sperm viability, making it a highly promising tool that could potentially… View Article

30 June 2025

A New Frontier in Female Infertility: Restoring Ovarian Function Through Stem Cell–Derived Proteins

A newly presented study by IVI at the 41st Annual Meeting of the European Society of Human Reproduction and Embryology (ESHRE) has demonstrated improved ovarian function in mice following the injection of a specific combination of key proteins The study, conducted in female mice with premature ovarian insufficiency (POI), resulted in a fivefold increase in… View Article

26 April 2025

Generating Sperm and Eggs from Stem Cells, Latest Advances in Artificial Intelligence, and the Next Revolution in Genetic Assessment

Barcelona hosts the congress of the world’s largest corporation exclusively dedicated to assisted human reproduction, bringing together over 1,300 professionals, researchers, and academics from 58 countries Denny Sakkas, Chief Scientific Officer IVIRMA North America and Associate Professor at Yale University School of Medicine, will discuss pioneering research on stem cell biology and tissue engineering aimed… View Article

PRESS ROOM CONTACTS

Ricardo Pedrós

Email: prensa@ivi.es
Phone number: (0034) 96 317 36 10
Calle Colón, 1 - 46004 (Valencia)

Press room